Siemens Healthineers AG is a global provider of healthcare technologies, solutions, and services. Spun off from Siemens AG, the company operates across four primary business segments: Imaging, Diagnostics, Varian, and Advanced Therapies. The Imaging segment, which accounts for approximately 55% of total revenue, offers a portfolio of diagnostic imaging equipment, including magnetic resonance imaging (MRI), computed tomography (CT), X-ray, and ultrasound systems. The Diagnostics segment (around 20% of revenue) provides in-vitro diagnostic products and services to healthcare providers and laboratories. The Varian segment (approximately 17% of revenue) specializes in radiation oncology treatments and software, supporting cancer care globally. The Advanced Therapies segment (roughly 9% of revenue) focuses on products and services for image-guided minimally invasive treatments. Geographically, the company has a global footprint, generating significant revenue from the Americas, the Europe, Middle East, and Africa (EMEA) region, and the Asia Pacific Japan region. Siemens Healthineers generates revenue through the sale of its medical equipment, as well as recurring revenue from long-term service contracts, software, and maintenance agreements. The company's competitive position is supported by its large installed base, continuous research and development investments, and established relationships with hospitals and medical centers worldwide.